cyclopentyl 2-(4-methylpiperazinomethyl)phenyl ketone, 97.0%, 1g

4-Chloro-5,7-difluoroquinoline, 98+%, 250mg

1-Bromo-3-(cyclopropylmethoxy)benzene, 95.0%, 1g

Tri-O-Acetyl-D-galactal, 95.0%, 10g

METHYL 2-AMINO-4-BROMO-5-METHOXYBENZOATE, 95.0%, 1g

2,5-Dibromofuran (stabilised with MgO), 95.0%, 100mg

Ethyl Heptadecafluorononanoate>98.0%(GC)5g

6-bromo-7-methoxy-2-methyl-1H,4H-pyrido[2,3-d]pyrimidin-4-one, 98%, 250mg

Plan PLPHi 10x/0.25 phase contrast IOS infinity corrected objective

Benzene, ROTICHROM® GC, 1 g, glass packaging

4-Aminomethyl quinoline hydrochloride, 95.0%, 5g

4-(3-HYDROXY-PROPOXY)-BENZOIC ACID METHYL ESTER, 95.0%, 2g

Ethyl 2-(4-amino-2-chlorophenyl)acetate, 97%, 1g